
Number of publications published per year by Valla, Dominique. (Source : PubMed)

Distribution of publications types for Valla, Dominique. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)
Tolerance and outcome of patients with unresectable hepatocellular carcinoma treated with sorafenib.
Eur J Gastroenterol Hepatol
2010
Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: Incidence and survival in hepatitis C patients with advanced fibrosis.
J. Hepatol.
2010
The impact of preoperative hepatic hydrothorax on the outcome of adult liver transplantation.
Eur J Gastroenterol Hepatol
2010;22;2

Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study.
Hepatology
2010;51;1
The spectrum of renal lesions in patients with cirrhosis: a clinicopathological study.
Liver Int.
2009
Insulin resistance and geographical origin: major predictors of liver fibrosis and response to peginterferon and ribavirin in HCV-4.
Gut
2009;58;12
A single-center surgical experience of 122 patients with single and multiple hepatocellular adenomas.
Gastroenterology
2009;137;5
Levels and initial course of serum alanine aminotransferase can predict outcome of patients with Budd-Chiari syndrome.
Clin. Gastroenterol. Hepatol.
2009;7;11
Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: a prospective magnetic resonance imaging and histological study.
Hepatology
2009;50;2

Cancer awareness in atypical thrombotic microangiopathies.
Oncologist
2009;14;8
[ See timeline ] [ See all publications ]
means that Valla, Dominique has 53 papers cited a least 53 times - methodology
Service d'Hépatologie, Hôpital Beaujon, AP-HP, INSERM U773-CRB3, Université Denis Diderot-Paris7, 100 Boulevard du Général Leclerc, 92110 Clichy, France.
Due mainly to homonyms, errors are possible and if you detect "false positives" or "false negatives" don't be too frustrated and please contact the webmaster.